Healthcare provider profile · identity verified

Peter V. Wentzel, MD

Family Practice · GRAFTON, WV · NPI 1952470841

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	302	66
Levothyroxine Sodium	Levothyroxine Sodium	238	35
Atorvastatin Calcium	Atorvastatin Calcium	236	52
Tamsulosin Hcl	Tamsulosin Hcl	169	31
Meloxicam	Meloxicam	165	41
Lisinopril	Lisinopril	161	39
Amlodipine Besylate	Amlodipine Besylate	152	40
Gabapentin	Gabapentin	149	35
Hydrochlorothiazide	Hydrochlorothiazide	147	33
Tramadol Hcl	Tramadol Hcl	145	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	136	28
Losartan Potassium	Losartan Potassium	126	29
Metformin Hcl Er	Metformin Hcl	126	23
Metoprolol Succinate	Metoprolol Succinate	122	27
Ozempic	Semaglutide	117	17
Sertraline Hcl	Sertraline Hcl	113	19
Jardiance	Empagliflozin	110	18
Citalopram Hbr	Citalopram Hydrobromide	105	17
Pantoprazole Sodium	Pantoprazole Sodium	105	21
Alprazolam	Alprazolam	97	18
Furosemide	Furosemide	97	22
Montelukast Sodium	Montelukast Sodium	92	18
Fluticasone Propionate	Fluticasone Propionate	88	47
Clonazepam	Clonazepam	84	suppressed
Temazepam	Temazepam	82	13
Duloxetine Hcl	Duloxetine Hcl	77	21
Spironolactone	Spironolactone	72	18
Trazodone Hcl	Trazodone Hcl	72	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	23
Metformin Hcl	Metformin Hcl	68	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	16
Clopidogrel	Clopidogrel Bisulfate	65	14
Triamcinolone Acetonide	Triamcinolone Acetonide	63	27
Glipizide Er	Glipizide	60	19
Albuterol Sulfate Hfa	Albuterol Sulfate	59	26
Famotidine	Famotidine	58	15
Rosuvastatin Calcium	Rosuvastatin Calcium	56	14
Pregabalin	Pregabalin	55	15
Prednisone	Prednisone	53	32
Terbinafine Hcl	Terbinafine Hcl	53	20
Amitriptyline Hcl	Amitriptyline Hcl	52	suppressed
Eliquis	Apixaban	50	11
Bupropion Hcl Sr	Bupropion Hcl	48	13
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Xarelto	Rivaroxaban	47	suppressed
Simvastatin	Simvastatin	45	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	29
Tresiba Flextouch U-100	Insulin Degludec	41	suppressed
Potassium Chloride	Potassium Chloride	40	11
Diclofenac Sodium	Diclofenac Sodium	39	suppressed
Allopurinol	Allopurinol	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	28
Meclizine Hcl	Meclizine Hcl	34	suppressed
Naproxen	Naproxen	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Carvedilol	Carvedilol	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Finasteride	Finasteride	27	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Mupirocin	Mupirocin	25	19
Trulicity	Dulaglutide	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Azithromycin	Azithromycin	23	17
Synthroid	Levothyroxine Sodium	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Amoxicillin	Amoxicillin	21	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Glipizide	Glipizide	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Atenolol	Atenolol	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Carisoprodol	Carisoprodol	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	13
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Diazepam	Diazepam	17	suppressed
Cefdinir	Cefdinir	16	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	14
Estradiol	Estradiol	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Nystatin	Nystatin	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Novolin N	Insulin Nph Human Isophane	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Armour Thyroid	Thyroid,pork	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Topiramate	Topiramate	13	suppressed
Baclofen	Baclofen	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Livalo	Pitavastatin Calcium	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error